In this article, we will discuss Ramucirumab (26). So, let’s get started.
Use in Specific Population
Pregn*ncy Category C
Based on its mechanism of action, Ramucirumab may cause fetal harm. Animal models link angiogenesis, VEGF and
VEGF Receptor 2 (VEGFR2) to critical aspects of female reproduction, embryo-fetal development, and post-natal
development. There are no adequate or well controlled studies of ramucirumab in pregn*nt women. If this drug is used
during pregnancy, or if the patient becomes pregn*nt while taking this drug, apprise the patient of the potential hazard to a